Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-1287-5p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 325, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
KLF10 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr8:102655573-102655596 PAR-CLIP POSITIVE DIRECT TarBase 7.0
LARP1 hsa-miR-1287-5p low: 0 high: 1 1 1 1 0.707
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr5:154813961-154813986 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CNOT8 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:154865278-154865303 PAR-CLIP POSITIVE DIRECT TarBase 7.0
CD109 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:73806953-73806974 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZFAND3 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr6:38061704-38061728 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PRR14 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr16:30651231-30651257 HITS-CLIP POSITIVE DIRECT TarBase 7.0
EIF4A2 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr3:186784643-186784670 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NRG1 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr8:32756504-32756521 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PALM2-AKAP2 hsa-miR-1287-5p low: 0 high: 1 1 1 1 0.673
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:110168960-110168988 PAR-CLIP POSITIVE DIRECT TarBase 7.0
SKI hsa-miR-1287-5p low: 0 high: 1 1 1 1 0.564
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:2307903-2307927 HITS-CLIP POSITIVE DIRECT TarBase 7.0
WIPI2 hsa-miR-1287-5p low: 0 high: 1 1 1 1 0.525
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr7:5225864-5225884 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DZIP1L hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr3:138064712-138064739 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SON hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr21:33558002-33558020 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ADPGK hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr15:72752214-72752232 PAR-CLIP POSITIVE DIRECT TarBase 7.0
SAFB hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr19:5667024-5667047 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MAML1 hsa-miR-1287-5p low: 0 high: 1 1 1 1 0.486
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr5:179773925-179773947 HITS-CLIP POSITIVE DIRECT TarBase 7.0
EMC10 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr19:50482597-50482624 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HIPK1 hsa-miR-1287-5p low: 0 high: 1 1 1 1 0.703
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:113940866-113940894 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PLXNB1 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr3:48425293-48425315 HITS-CLIP POSITIVE DIRECT TarBase 7.0
GAPVD1 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:125307832-125307855 PAR-CLIP POSITIVE DIRECT TarBase 7.0